{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:04:22Z","timestamp":1790935462363,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jbspin.2007.07.011","type":"journal-article","created":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T00:04:09Z","timestamp":1199923449000},"page":"303-310","source":"Crossref","is-referenced-by-count":55,"title":["Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II)"],"prefix":"10.1016","volume":"75","author":[{"given":"Peyman","family":"Hadji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Minne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Fardellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Licata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Devas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiva","family":"Masanauskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Barrett-Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2007.07.011_bib1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2007.07.011_bib2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","article-title":"Treatment of postmenopausal osteoporosis","volume":"359","author":"Delmas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2007.07.011_bib3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","article-title":"Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group","volume":"42","author":"Hochberg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2007.07.011_bib4","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jc.87.4.1586","article-title":"Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents","volume":"87","author":"Hochberg","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2007.07.011_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4065\/80.3.379","article-title":"The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy","volume":"80","author":"Epstein","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jbspin.2007.07.011_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.0301202","article-title":"Oral daily ibandronate prevents bone loss in early postmenopausal women with osteoporosis","volume":"19","author":"McClung","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2007.07.011_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMcp043801","article-title":"Postmenopausal osteoporosis","volume":"353","author":"Rosen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2007.07.011_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1891\/0739-6686.18.1.48","article-title":"Adherence in chronic disease","volume":"18","author":"Dunbar-Jacob","year":"2000","journal-title":"Annu Rev Nurs Ras"},{"key":"10.1016\/j.jbspin.2007.07.011_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.12927\/hcq..16941","article-title":"Concordance, compliance and adherence in healthcare: closing gaps and improving outcomes","volume":"8","author":"Wahl","year":"2005","journal-title":"Healthc Q"},{"key":"10.1016\/j.jbspin.2007.07.011_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Drug therapy \u2013 adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jbspin.2007.07.011_bib11","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079905X61875","article-title":"Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis","volume":"21","author":"Cramer","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2007.07.011_bib12","first-page":"S513","article-title":"Medication persistence is improved with less frequent dosing of bisphosphonates, but remains inadequate [abstract]","volume":"50","author":"Ettinger","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2007.07.011_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinthera.2006.01.002","article-title":"Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis","volume":"28","author":"Penning-van Beest","year":"2006","journal-title":"Clin Ther"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2007.07.011_bib14","first-page":"364","article-title":"Persistence and compliance with daily- and weekly-administered bisphosphonates in German women with osteoporosis [abstract]","volume":"64","author":"Bartl","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2007.07.011_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pec.2004.08.006","article-title":"Preferences for medical collaboration: patient-physician congruence and patient outcomes","volume":"57","author":"Jahng","year":"2005","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jbspin.2007.07.011_bib16","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0149-2918(03)80222-9","article-title":"The impact of reducing dose frequency on health outcomes","volume":"25","author":"Richter","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jbspin.2007.07.011_bib17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.jbspin.2007.07.011_bib18","first-page":"436","article-title":"Improving medication compliance \u2013 a review of selected issues","volume":"13","author":"Sclar","year":"1991","journal-title":"Clin Ther"},{"key":"10.1016\/j.jbspin.2007.07.011_bib19","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0149-2918(02)80085-6","article-title":"Patient preference for once-weekly alendronate 70mg versus once-daily alendronate 10mg: a muticenter, randomized, open-label, cross-over study","volume":"24","author":"Simon","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jbspin.2007.07.011_bib20","first-page":"31","article-title":"Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study","volume":"30","author":"Simon","year":"2005","journal-title":"Female Patient"},{"key":"10.1016\/j.jbspin.2007.07.011_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2007.07.011_bib22","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1359\/JBMR.050313","article-title":"Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2007.07.011_bib23","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1185\/030079905X74862","article-title":"Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)","volume":"21","author":"Emkey","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2007.07.011_bib24","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/qhc.0100002","article-title":"Measuring patients\u2019 preferences for treatment and perceptions of risk","volume":"1","author":"Bowling","year":"2001","journal-title":"Qual Health Care"},{"key":"10.1016\/j.jbspin.2007.07.011_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/biomet\/56.1.75","article-title":"An exact test for comparing matched proportions in crossover designs","volume":"56","author":"Gart","year":"1969","journal-title":"Biometrika"},{"key":"10.1016\/j.jbspin.2007.07.011_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2307\/2346652","article-title":"The comparison of success rates in cross-over trials in the presence of an order effect","volume":"30","author":"Prescott","year":"1981","journal-title":"Appl Stat"},{"key":"10.1016\/j.jbspin.2007.07.011_bib27","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM199406303302611","article-title":"Incorporating patients preferences into medical decisions","volume":"330","author":"Kassirer","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jbspin.2007.07.011_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1369-6513.2000.00073.x","article-title":"The medical visit context of treatment decision-making and the therapeutic relationship","volume":"3","author":"Roter","year":"2000","journal-title":"Health Expect"},{"key":"10.1016\/j.jbspin.2007.07.011_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.maturitas.2003.12.012","article-title":"Patients with osteoporosis prefer once weekly to once daily dosing with alendronate","volume":"48","author":"Kendler","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.jbspin.2007.07.011_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00198-002-1370-3","article-title":"Tolerability and compliance with risedronate in clinical practice","volume":"14","author":"Hamilton","year":"2003","journal-title":"Osteoporos Int"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2007.07.011_bib31","first-page":"46","article-title":"Estrogen therapy: from women's choice to women's preference","volume":"5","author":"Lachowsky","year":"2002","journal-title":"Climacteric"},{"key":"10.1016\/j.jbspin.2007.07.011_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2648.1996.01993.x","article-title":"Patient compliance: recognition of factors involved and suggestions for promoting compliance with therapeutic regimens","volume":"24","author":"Cameron","year":"1996","journal-title":"J Adv Nurs"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2007.07.011_bib33","first-page":"S290","article-title":"Improved persistence in women treated with once-monthly ibandronate vs weekly bisphosphonates: a first look [abstract]","volume":"21","author":"Silverman","year":"2006","journal-title":"J Bone Miner Res"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X07003089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X07003089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T19:13:45Z","timestamp":1557170025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X07003089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1297319X07003089"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2007.07.011","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}